Pie Medical Imaging BV (PMI) announced today that they have signed an agreement with the Cardiovascular Research Foundation (CRF) to begin a close collaboration. Under this agreement the CRF Clinical Trials Center will use PMI’s solutions in their Angiographic Core Laboratory for clinical research and multi-center trials. As part of the agreement, CRF will also support further development of PMI’s new state-of-the-art products for analysis and visualization of medical images. The CRF Clinical Trials Center (CTC) plans and executes clinical investigations from first-in-man studies to large, multicenter, international trials and provides expert, independent qualitative and quantitative analyses of clinical and imaging data.
“We selected PMI for its well renowned software solutions for clinical trials and research in the areas of interventional cardiology, endovascular medicine and structural heart disease, as well as their ongoing and groundbreaking developments in the field of cardiovascular imaging solutions,”
said Philippe Genereux, MD, Director of Angiographic Core Laboratory at the CRF Clinical Trials Center.
“PMI is pleased to work with CRF, a highly recognized international research and educational institution. Our collaboration with CRF gives PMI the opportunity to leverage CRF’s knowledge to further enhance our products and in ongoing development of new state-of-the-art solutions,”
said Boudewijn Verstraelen, CEO at PMI.
Pie Medical Imaging BV
Pie Medical Imaging BV has 30 years of experience in cardiovascular analysis software and is well known for its CAAS and 3mensio product lines. Pie Medical Imaging is based in Maastricht, the Netherlands. Both Pie Medical Imaging and 3mensio are part of the Esaote group. Esaote S.p.A. is besides provider of IT solutions a leading manufacturer of ultrasound and dedicated MRI equipment. For more information on Esaote, visit www.esaote.com. For information on CAAS and 3mensio analysis software solutions visit www.piemedicalimaging.com.